Search Results - "Blocker S"

This result is not displayed to guests.
Login for full access.

Chemoenzymatic Protocol for the Synthesis of Enantiopure β -Blocker (S)-Bisoprolol.

Authors: Bocquin, Lucas Jacobsen, Elisabeth Egholm

Source: Catalysts (2073-4344). Jan2023, Vol. 13 Issue 1, p54. 9p.

Risk factors for CRS and ICANS with tarlatamab in small cell lung cancer and associated efficacy outcomes: Insights from clinical practice.

Authors: Blocker S Kim D Cavalieri CC et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 May 02; Vol. 238, pp. 116686. Date of Electronic Publication: 2026 Mar 23.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Double-cuff versus single-cuff bronchial blockers for video-assisted thoracoscopic lobectomy: A randomized controlled trial.

Authors: Tang, Guoliang Li, Xiaobin Liu, Huaqin et al.

Source: PLoS ONE. 5/21/2026, Vol. 21 Issue 5, p1-11. 11p.

Real-World Outcomes of Abemaciclib Dose-Escalation Strategy in High-Risk Early Breast Cancer.

Authors: Lad N Blocker S Monson T et al.

Source: Clinical breast cancer [Clin Breast Cancer] 2026 May; Vol. 26 (5), pp. 57-62. Date of Electronic Publication: 2026 Apr 06.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE

Outcomes of Concurrent Radiotherapy With Tarlatamab in Extensive-Stage Small Cell Lung Cancer From the DLL3 PanTUMOR Database.

Authors: Kim D Blocker S Cavalieri CC et al.

Source: Clinical lung cancer [Clin Lung Cancer] 2026 Apr; Vol. 27 (3), pp. 252-258.e3. Date of Electronic Publication: 2026 Jan 30.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE

The EZ- Blocker^®- A Safer Alternative in Complex Airway Scenarios: A Case Series.

Authors: Kumar, Suda Naveen Panchanathan, Ilangovan Singh, Shruti et al.

Source: Annals of Cardiac Anaesthesia. Oct-Dec2025, Vol. 28 Issue 4, p480-485. 6p.

Optimizing position-specific preparation: Long-term pre-match warm-up external load analysis using micro-sensor integrated LPS in elite female volleyball players.

Authors: Altundağ, Emre Cengizel, Elif Akarçeşme, Cengiz et al.

Source: BMC Sports Science, Medicine & Rehabilitation. 10/22/2025, Vol. 17 Issue 1, p1-9.

The Interrelationships of Three Change of Direction Ability Tests in Elite Female Volleyball Players: An Exploratory Study.

Authors: Wright, Will C. Aguiar, Elroy J. Winchester, Lee J. et al.

Source: Sports (2075-4663). Oct2025, Vol. 13 Issue 10, p339.

Histopathological and Molecular Characterization of Amlodipine-Induced Gingival Enlargement: Insights into Fibrotic Mechanisms.

Authors: Mojsilović, Jana Kostić, Marina Vujović Ristić, Sanja et al.

Source: Pharmaceuticals (14248247). Jan2026, Vol. 19 Issue 1, p45. 13p.

Safety, Efficacy, and Central Nervous System Control in Patients with High Baseline Risk Factors Treated with Tarlatamab for SCLC or Extrapulmonary Small Cell Carcinoma.

Authors: Mullangi S Lekkala MR Blocker S et al.

Source: JTO clinical and research reports [JTO Clin Res Rep] 2025 Jul 03; Vol. 6 (11), pp. 100875. Date of Electronic Publication: 2025 Jul 03 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101769967 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3643 (Electronic) Linking ISSN: 26663643 NLM ISO Abbreviation: JTO Clin Res Rep Subsets: PubMed not MEDLINE

Green Chemo-Enzymatic Protocols for the Synthesis of Enantiopure β -Blockers (S)-Esmolol and (S)-Penbutolol.

Authors: Troøyen, Susanne Hansen Bocquin, Lucas Tennfjord, Anna Lifen et al.

Source: Catalysts (2073-4344). Sep2022, Vol. 12 Issue 9, pN.PAG-N.PAG. 12p.

Losartan in the Era of Emerging Contaminants: A Multi-Criteria Approach for Efficient and Sustainable Remediation.

Authors: Georgin, Jordana Dehmani, Younes El Messoaudi, Noureddine et al.

Source: Molecules. May2026, Vol. 31 Issue 10, p1746. 51p.

Chemo-Enzymatic Synthesis of Enantiopure (−)-Nebivolol Catalyzed by Lipase B from Candida antarctica.

Authors: Hoem, Eline Flo Aasen, Sara Massacrier, Aurore et al.

Source: Catalysts (2073-4344). Mar2026, Vol. 16 Issue 3, p256. 17p.

Polymeric Membrane-Based Systems in Transdermal Drug Delivery.

Authors: Donato, Laura Bernardo, Paola

Source: Polymers (20734360). Feb2026, Vol. 18 Issue 3, p376. 51p.

Psychological, Cardiovascular, and Skeletal Long-term Outcomes of Hormone Treatment Among Transgender Adolescents: A Systematic Review.

Authors: Prokop, Hailey G. Dreyer, Anna J. Palmateer, Brandon L.

Source: Journal of Psychosexual Health. Jan2026, Vol. 8 Issue 1, p14-30. 17p.

Biomechanical analysis of distance adjustment in volleyball overhead pass.

Authors: Ozawa, Yu Yamada, Hiroshi Ozawa, Shoh et al.

Source: Sports Biomechanics. Feb2025, Vol. 24 Issue 2, p440-457.

Synthesis of Enantiopure (S)-Atenolol by Utilization of Lipase-Catalyzed Kinetic Resolution of a Key Intermediate.

Authors: Hansen, Mari Bergan Tennfjord, Anna Lifen Blindheim, Fredrik Heen et al.

Source: International Journal of Molecular Sciences. Mar2024, Vol. 25 Issue 6, p3497. 11p.

Cardiovascular Side Effects of Anthracyclines and HER2 Inhibitors among Patients with Breast Cancer: A Multidisciplinary Stepwise Approach for Prevention, Early Detection, and Treatment.

Authors: Mauro, Ciro Capone, Valentina Cocchia, Rosangela et al.

Source: Journal of Clinical Medicine. Mar2023, Vol. 12 Issue 6, p2121. 15p.

A year in review: new treatments and expanded indications in dermatology in 2024.

Authors: McGrath, Lauren N. McGrath, Lila G. Edminister, John R.

Source: Journal of Dermatological Treatment. Dec2025, Vol. 36 Issue 1, p1-7. 7p.